medical management of ulcerative colitis
Last reviewed 10/2023
Medical management of IBD varies with respect to disease severity:
Considered in terms of:
- acute attacks
- maintenance of remission of IBD
management of acute ulcerative colitis
leukapharesis for ulcerative colitis (UC)
clinical based scales to assess severity of ulcerative colitis (UC)
infliximab in Crohn's disease and ulcerative (UC) colitis
NICE guidance - Tofacitinib for moderately to severely active ulcerative colitis
NICE guidance - Vedolizumab for treating moderately to severely active ulcerative colitis
NICE guidance - Ustekinumab for treating moderately to severely active ulcerative colitis
faecal microbiota transplantation (FMT) in ulcerative colitis (UC)
filgotinib for treating moderately to severely active ulcerative colitis
ozanimod for treating moderately to severely active ulcerative colitis
upadacitinib for treating moderately to severely active ulcerative colitis (UC)
mirikizumab for treating moderately to severely active ulcerative colitis (UC)